Tµi liÖu tham kh¶o b»ng tiÕng Anh

Tµi liÖu tham kh¶o b»ng tiÕng Anh

56. 
    Abate N, Chandalia M (2001) “ The impact of ethnicity and type 2 diabetes: focus on Asian Indians”. J Diabetes Complications, pp. 320-327.
    
57. 
    Astrup A (2001) “ Health lifestyles in Europe: Prevention of obesity and type II diabetes by diet and physical activity”, Public Health Nutr, 4, pp 449-515.
    
58. 
    Application for the approval of isomalt (2003), Regulation (EC) No258/97 of the European parliament and of the Council of 27^th Jan 1997 concerning novel foods and novel food ingredient, pp. 41-45.
    
59. 
    Basit A, Hydrie MZ, Ahmed K, Hakeem R (2002) “Prevalence of diabetes, impaired fasting glucose and associated risk factors in a rural area of Baluchistan province according to new ADA criteria”, J Pak Med Assoc, pp. 357-360.
    
60. 
    Bell D (2000) “Pathophysiology of type 2 diabetes and its relationship to new therapeutic Approaches”, Diabetes Educ, 26 Suppl, pp. 4-7.
    
61. 
    Bailes BK (2002) “Diabetes mellitus and its chronic complications”, Aorn J, pp. 266-276.
    
62. 
    Bermudez OI, Velez-Carrasco W, Schaefer EJ, Tucker KL (2002) “Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes”,. Am J Clin Nutr, pp. 1214-1221.
    
63. 
    Betteridge DJ (2000) “Diabetic dyslipidaemia”, Diabetes Obes Metab, 2 Suppl 1, S31-6.
    
64. 
    Birkeland KI, Claudi T, Hansteen V, Hanssen KF, Hjermann I, Jenssen T, Jervell J, Os I (2000) “Prevention of cardiovascular disease in type 2 diabetes Tidsskr Nor Laegeforen, pp. 120(21), pp. 2554-2559.
    
65. 
    Brown SA, Garcia AA, Kouzekanani K, Hanis CL (2002) “Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative. Diabetes Care, pp. 25(2), pp. 259-268.
    
66. 
    Burke JP, Williams K, Haffner SM, Villalpando CG, Stern MP (2001) “Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico”. Diabetes Care, pp. 1573-1578.
    
67. 
    Bachmann W, Hasbeck M and et al (1984). Investigation of the methabolic effects of accute dose of platinit- compatison with fructose and sucrose in type 2 diabetes. AKT E Mahr, pp. 65-70.
    
68. 
    Brand-Miller JC and et al (1991) Low-glycemic index foods improve long-term glycemic control in NIDDM. Am J Clin Nutr, pp. 95-101
    
69. 
    Cargo M, Levesque L, Macaulay AC, McComber A, Desrosiers S, Delormier T, Potvin L (2004), “Community governance of the Kahnawake Schools Diabetes Prevention Project, Kahnawake Territory, Mohawk Nation, Canada. Health Promot Int, pp. 177-187.
    
70. 
    Casimiro C, Garcia de Lorenzo A, Usan L (2001) “Nutritional and metabolic status and dietetic evaluation in institutionalized elderly patients with non-insulin-dependent diabetes mellitus”, Nutr Hosp, pp. 104-111.
    
71. 
    Cole SM, Teufel-Shone NI, Ritenbaugh CK, Yzenbaard RA, Cockerham DL (2001) “Dietary intake and food patterns of Zuni adolescents”, J Am Diet Assoc, pp. 802-806.
    
72. 
    Conlon P.C (2001) “A practical approach to type 2 diabetes". Nurs Clin North Am, pp. 193-202.
    
73. 
    Connor H, Annan F, Bunn E, Frost G, McGough N, Sarwar T, Thomas B (2003), “The implementation of nutritional advice for people with diabetes”, Diabet Med, pp. 786-807.
    
74. 
    Costacou T, Mayer-Davis EJ. (2003) “Nutrition and prevention of type 2 diabetes”, Annu Rev Nutr, pp. 147-170.
    
75. 
    Catherine Lau, Kristine Ferch (2005) “Dietary glycemic index, glycemic load, fiber, simple surgar, and insulin resistance”, Diabet care, pp. 1397-1404
    
76. 
    Detournay B, Cros S, Charbonnel B, Grimaldi A, Liard F, Cogneau J, Fagnani F, Eschwege E (2000), “Managing type 2 diabetes in France: the ECODIA survey”, Diabetes Metab, pp. 363-369.
    
77. 
    Diamond J (2003), “The double puzzle of diabetes”, Nature, pp. 599-602.
    
78. 
    Drost H, Gierlich P and et al (1980). Blood glucose and serum insulin after oral administration of palatinit (isomalt) in comparision with glucose in diabetics of the late- onset type. Verh. Dtsch.Ges. Int.Med 1980, pp. 978-81
    
79. 
    Faglia E, Favales F, Calia P, Paleari F, Segalini G, Gamba PL, Rocca A, Musacchio N, Mastropasqua A, Testori G, Rampini P, Moratti F, Braga A, Morabito A (2002), “Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD)”, Diabetes Care, pp. 2032-2036.
    
80. 
    Frank B, Joanm E et al (2001), “Diet lifestyle and the risk of type 2 DM inwomen”. The new England Journal od medicine, Vol.345, no.11, pp.790-97.
    
81. 
    Fisher L, Chesla CA, Skaff MM, Gilliss C, Mullan JT, Bartz RJ, Kanter RA, Lutz CP (2000), “The family and disease management in Hispanic and European-American patients with type 2 diabetes”. Diabetes Care, pp. 267-272.
    
82. 
    Foliaki S, Pearce N (2003), “Prevention and control of diabetes in Pacific people”, BMJ, 327(7412), pp. 437-439.
    
83. 
    Freire RD, Cardoso MA, Shinzato AR, Ferreira SR (2003), “Nutritional status of Japanese-Brazilian subjects: comparison across gender and generation”. Br J Nutr, 89(5), pp.705-713.
    
84. 
    Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. (2003) “Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes”. N Engl J Med, 348(5), pp. 383-393.
    
85. 
    Gomis R, Chiasson J L (1998) “ The STOP-NIDDM Trial : an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus”. Diabetes Care, 26(1), pp.1720-1725.
    
86. 
    Gilis-Januszewska A, Szurkowska M, Szybinski K, Glab G, Szybinski Z, Spodaryk K, Urbanik A. “The efficacy of non-pharmacological intervention in obese patients with newly diagnosed diabetes mellitus type II”. Pol Arch Med Wewn, pp. 853-860.
    
87. 
    Goldhaber-Fiebert JD, Goldhaber-Fiebert SN, Tristan ML, Nathan DM (2003), “Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica”. Diabetes Care, pp. 24-29.
    
88. 
    Gorman C (2003), “Why so many of us are getting diabetes”, Time, pp. 58-69.
    
89. 
    Gourdy P, Ruidavets JB, Ferrieres J, Ducimetiere P, Amouyel P, Arveiler D, Cottel D, Lamamy N, Bingham A, Hanaire-Broutin H (2001), “Prevalence of type 2 diabetes and impaired fasting glucose in the middle-aged population of three French regions. The MONICA study 1995-97”, Diabetes Metab, pp. 347-358.
    
90. 
    Grandinetti A, Keawe'aimoku Kaholokula J, Chang HK, Chen R, Rodriguez BL, Melish JS, Curb JD (2002), “Relationship between plasma glucose concentrations and Native Hawaiian Ancestry: The Native Hawaiian Health Research Project”, Int J Obes Relat Metab Disord, pp. 778-782.
    
91. 
    Glen Fernandes and et al (2005) “Glycemic index of potatoes commonly consumed in North America”, A J diet Assoc 105: pp. 557-562
    
92. 
    Haney PM (2001), “Effective diabetes education in the home care setting”, Home Care Provid, pp. 20-29.
    
93. 
    Harwell TS, Moore K, McDowall JM, Helgerson SD, Gohdes D (2003), “Cardiovascular risk factors in Montana American Indians with and without Diabetes”, Am J Prev Med, pp. 265-269.
    
94. 
    Hjelm K, Mufunda E, Nambozi G, Kemp J. (2003), “Preparing nurses to face the pandemic of diabetes mellitus: a literature review”, J Adv Nurs, pp. 424-434.
    
95. 
    Holcomb S.S (2001), “Lowering the risk of Type 2 diabetes”, Nurse Pract, Suppl pp.1-8.
    
96. 
    Janket SJ, Manson JE, Sesso H, Buring JE, Liu S. (2003) “A prospective study of sugar intake and risk of type 2 diabetes in women”, Diabetes Care, pp. 1008-1015.
    
97. 
    Jefferson VW, Melkus GD, Spollett GR (2000), “Health-promotion practices of young black women at risk for diabetes”, Diabetes Educ, pp. 295-302.
    
98. 
    Jermendy G. (2003), “Is type-2 diabetes mellitus preventable?”, Orv Hetil. pp. 1909-1917.
    
99. 
    Johnson KH, Bazargan M, Bing EG (2000), “Alcohol consumption and compliance among inner-city minority patients with type 2 diabetes mellitus”, Arch Fam Med, pp. 964-970.
    

101.Jennie Brand- Miller, et al (2003) “Low- glycemic index diets in the management of diabetes”, Diabetes care, 26(8) 2261-2270

102.Kanaya AM, Narayan KM. (2003), “Prevention of type 2 diabetes: data from recent trials”. Prim Care, pp. 511-526.

103.Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM (2002), “Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin”, N Engl J Med, pp. 393-403.

104.Kaye Foster-Powell et al (2002), “International table of glycemic index and glycemic load values:2002”, Am J Nutr 2002;76:5-56

105.Kosaka K (2002), “Pathogenesis of type 2 diabetes mellitus from the viewpoint of clinical Epidemiology”, Nippon Rinsho, 60 Suppl 7, pp. 423-467.

106.Kanji A.O, et al (2002) “Diabetic dyslipidaemia in Kuwait” Med Princ Pract, 11 Suppl 2, pp. 47-55.

107.Kriska A (2000), “Physical activity and the prevention of type 2 diabetes mellitus: how much for how long?”, Sports Med, pp. 147-151.

108.Kubaszek A, Pihlajamaki J, Komarovski V, Lindi V, Lindstrom J, Eriksson J, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Tuomilehto J, Uusitupa M, Laakso M (2003), “Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study”, Diabetes, pp. 1872-1876.

109.Kumanyika S, Jeffery RW, Morabia A, Ritenbaugh C, Antipatis VJ (2002), “Obesity prevention: the case for action”, Int J Obes Relat Metab Disord, pp. 425-436.

110.Kamendola C (2003), “Early and more vigorous detection of diabetes”,J Cardiovasc Nurs, pp. 103-117.

111.Li G, Hu Y, Yang W, Jiang Y, Wang J, Xiao J, Hu Z, Pan X, Howard BV, Bennett PH (2002), “Effects of insulin resistance and insulin secretion on the efficacy of interventions to retard development of type 2 diabetes mellitus: the DaQing IGT and Diabetes Study”. Diabetes Res Clin Pract, pp. 193-200.

112.Liao D, Asberry PJ, Shofer JB, Callahan H, Matthys C, Boyko EJ, Leonetti D, Kahn SE, Austin M, Newell L, Schwartz RS, Fujimoto WY (2002), “Improvement of BMI, body composition, and body fat distribution with lifestyle modification in Japanese Americans with impaired glucose tolerance”. Diabetes Care, pp. 1504-1510.

113.Lako JV, Nguyen VC(2001) “Dietary patterns and risk factors of diabetes mellitus among urban indigenous women in Fiji”. Asia Pac J Clin Nutr, pp. 188-93.116.

114.Matsuoka K, et al (2000), “Genetic and environmental interaction in Japanese type 2 diabetics”, Diabetes Res Clin Pract, 50 Suppl 2, pp. 17-22.

115.Mc Farlane SI, Shin JJ, Rundek T, Bigger JT (2003), “Prevention of type 2 diabetes”, Curr Diab Rep, pp. 235-41.

116.Meneilly GS, Tessier D (2001), “Diabetes in elderly adults”, J Gerontol A Biol Sci Med Sci, pp. 5-13.

117.Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP (2001), “The continuing epidemics of obesity and diabetes in the United States”, JAMA, pp. 1195-1200.

118.Neelon FA, Ronald JS (2003), “The deadly sins and diabetes”, N C Med J, pp. 138-149.

119.Nicollerat JA (2000), “Elevated plasma glucose levels increase risk for complications”, Diabetes Educ, 26 Suppl 1, pp. 11-13.

120.Nilsen TI, Vatten LJ (2001), “Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis”, Br J Cancer, pp. 417-422.

121.Okosun IS (2000), “Ethnic differences in the risk of type 2 diabetes attributable to differences in abdominal adiposity in American women”, J Cardiovasc Risk, pp. 425-430.

122.Paul S. Levy and Stanley Lemeshow (1990),Sample Size for Sample Survey, Sampling of population: methods and application. pp. 175-186-243.

123.Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Tousoulis D, Toutouza M, Toutouzas P, Stefanadis C, (2004), “Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study”, Am Heart J, pp. 106-112.

124.Perry IJ (2002), “Healthy diet and lifestyle clustering and glucose intolerance”. Proc Nutr Soc, pp. 543-551.

125.Popkin BM (2001), “Nutrition in transition: the changing global nutrition challenge”, Asia Pac J Clin Nutr, 10 Suppl 1, pp. 8-13.

126.Racette SB, Weiss EP, Obert KA, Kohrt WM, Holloszy JO (2001), “Modest lifestyle intervention and glucose tolerance in obese African Americans”, Obes Res, pp. 348-355.

127.Reed JW et al (2002), “Diabetes: update on management and therapy”, Ethn Dis, pp. 2-20.

128.Rosenstock J et al (2000), “Treatment strategies and new therapeutic advances for type 2 diabetes”,. Diabetes Educ, 26 Suppl, pp. 14-18.

129.Ross R, Janssen I, Tremblay A (2000), “Obesity reduction through lifestyle modification”. Can J Appl Physiol, pp. 1-18.

130.Rothenbacher D, Ruter G, Saam S, Brenner H (2002), “Management of patients with type 2 diabetes. Results in 12 practices of general practitioners”, Dtsch Med Wochenschr, pp. 1183-1187.

131.Rowley KG, O'Dea K (2001), “Diabetes in Australian aboriginal and Torres Strait Islander peoples”, P N G Med J, pp. 164-170.

132.Rudolf Chlup et al (2004) “Ditermination of the glycemic index of selected foods(white bread and cereal bars) in healthy person”

133.Strup A et al (2001) “Healthy lifestyles in Europe: prevention of obesity and type II diabetes by diet and physical activity”, Public Health Nutr, pp. 499-515.

134.Sartorelli DS, Franco LJ (2003), “Trends in diabetes mellitus in Brazil: the role of the nutritional transition”. Cad Saude Publica, 19 Suppl 1, pp. 29-36.

136.Scheen AJ, et al (2003), “Current management strategies for coexisting diabetes mellitus and obesity” Drugs, pp. 1165-1184.

137. Schwedes U, et al. (2002) “How to take care by themselves for reducing the risk of a patient developing type 2 diabetes” Diabetes Care 2002, pp.1928-1932
138.Schuster DP, Duvuuri V (2002), “Diabetes mellitus”, Clin Podiatr Med Surg, pp. 79-107.

139.Scott CL, et (2001), “Diagnosis, prevention, and intervention for the metabolic syndrome”, Am J Cardiol, pp. 35-42.

140.Siebert G, Grupp U and Heikel K (1975), Studies on issomaltiol, Nutr,Methabol, pp. 191-196.

141.Solomon CG, et al (2003), “Reducing cardiovascular risk in type 2 diabetes”, N Engl J Med, pp. 457-459.

142.Sorensen TI, et al (2000), “The changing lifestyle in the world. Body weight and what else?”, Diabetes Care, 23 Suppl 2, pp.1-4.

143.Sydney University Glucemid Index Rearch Serve (SUGIS) (2002)

144.Taskinen MR, et al (2002), “Controlling lipid levels in diabetes”, Acta Diabetol, 39 Suppl 2, pp.29-34.

145.Taylor K, et al (2001), “Impaired glucose tolerance: obesity and inactivity as modifiable risk factors”, Adv Nurse Pract, pp.59-61.

146.Thiebaud D, Jacot E and at al (1984) “Comparative study of Isomalt and sucrose by means of continuous indirect calorimetry” Metabolis 1984, pp. 808.

147.Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A (2001), “Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance”, N Engl J Med, pp.1343-1350.

148.Woo J, Ho SC, Sham A, Sea MM, Lam KS, Lam TH, Janus ED (2003), “Diet and glucose tolerance in a Chinese population” Eur J Clin Nutr, pp. 523-530.

149.Woo J, Ho SC, Yu AL (2002), “Lifestyle factors and health outcomes in elderly Hong Kong chinese aged 70 years and over” Gerontology, pp. 234.

150.Whai F, Fu D, Du S, Ge K, Chen C, Popkin BM (2002), “What is China doing in policy-making to push back the negative aspects of the nutrition transition?”, Public Health Nutr, pp. 269-273.

151.WHO/WPRO: Type 2 diabetes “ Practical targets and treatment”. Fouth edition (2006).

152.Woleve TMS, Jenkins DM (1990). Glycemic index of food in individual subjects. Am J Clin Nutr, pp. 126-32.

153.Woleve TMS, Jenkins DM, Vuksan V (1991). The glycemic index: methodology and clinical implication. Am J Clin Nutr, pp. 126-132.

1. 
   Lª Phong, NguyÔn ThÞ L©m (2008), ‘‘§¸nh gi¸ ban ®Çu vÒ kÕt qu¶ can thiÖp phßng chèng ®¸i th¸o ®­êng ë nh÷ng ng­êi cã yÕu tè nguy c¬’’, T¹p chÝ Y häc thùc hµnh, sè 10-2008, Bé Y tÕ, Tr93-97
   
2. 
   Lª Phong, NguyÔn ThÞ L©m, T¹ V¨n B×nh (2008) ‘‘HiÖu qu¶ t­ vÊn thay ®æi hµnh vi dinh d­ìng vµ luyÖn tËp ë c¸c ®èi t­îng tiÒn ®¸i th¸o ®­êng t¹i Thanh Ho¸’’, T¹p chÝ Y häc thùc hµnh, sè 11-2008. Bé Y tÕ, Tr3-8